A Conversation with Ultragenyx’s Chief Medical Officer, Camille Bedrosian to discuss Insights into Future LC-FAOD Research. Also hear from Ultragenyx’s Global Metabolic Dietitian, Bridget Reineking on How to Use the Newly FDA Approved Medicine.
Ultragenyx Q&A – A Conversation with Ultragenyx’s CMO and Global Metabolic Dietitian
